At a Glance
CTI Life Sciences Fund is a venture capital firm founded in 2006. CTI Life Sciences Fund is a leading Canadian biotech venture capital firm with a global footprint. The firm focuses on Pre-Seed, Seed, Series A, Series B+ investments across sectors including Aerospace & Defense, Digital Health, Other, Consumer, Fintech.
“Invests in early-stage life sciences and biotechnology companies developing innovative therapeutics and medical technologies.”
CTI Life Sciences Fund primarily invests at the Pre-Seed, Seed, Series A, Series B+ stages. This means they focus on companies that are at the earliest idea or prototype phase.
CTI Life Sciences Fund focuses on investments in Aerospace & Defense, Digital Health, Other, Consumer, Fintech. Their portfolio reflects deep expertise and networks within these sectors.
CTI Life Sciences Fund's typical investment check size ranges from $. to $.. Actual amounts may vary based on the stage, sector, and specific opportunity.